Curi Bio
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
201 Elliott Ave W, Seattle, Washington, ...Phone Number
(800) 913-4403Website
www.curibio.comRevenue
$10.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
2
1
1
About Curi Bio
Curi Bio unlocks novel workflows and delivers functional human data to inform biopharmaceutical R&D decision making. Through an integrated platform featuring advanced 3D tissue models of disease, biosystems enabling clinically relevant functional analyses, and advanced automated data analysis, Curi Bio blends functional and analytical assessments for drug safety, efficacy, and potency. By offering leading global pharmaceutical end users an integrated preclinical platform along with highly predictive human stem cell tissue models to generate clinically-relevant data, Curi Bio is bridging the gap between preclinical R&D and clinical outcomes, accelerating the discovery and development of safer, more effective medicines.Explore more
Curi Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Curi Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Curi Bio recently announced quarterly report
Check if Curi Bio has recently received funding, and reach out quickly before it becomes old news!
Check out if Curi Bio is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Curi Bio
Funding: Get notified immidiatlly once Curi Bio has new funding data
Curi Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Click to see if Curi Bio had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Curi Bio launches new products
Recommended Actions
Find VP level buyers at Curi Bio
Find more new buyers
Compare Similar Companies to Curi Bio
Compare insights from companies similar to Curi Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Curi Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Curi Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Curi Bio.
Curi Bio financials insights
Gather financial insights about Curi Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
2021
Series A
$16M
2025
Series B
$10M
Curi Bio Tech Stack
A closer look at the technologies used by Curi Bio
Most Recent Scoops
Event
Product Marketing, Events, Sales, Search, Laboratory Operations, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Funding
Funding
Facilities Relocation / Expansion
Curi Bio is planning to move offices in February 2025. The move will impact approximately 11 employees at the existing office located at 3000 Western Ave, Suite #400, Seattle, WA.
Facilities Relocation/Expansion
Award
Award, Finance
Funding
Project
Product Development
Curi Bio News & Media
Nicholas Geisse Email & Phone Number | Chief Executive Officer at Curi Bio - Saleshandy
To contact Nicholas Geisse, Chief Executive Officer at Curi Bio or send an email to ni**@nanosurfacebio.com or call 61*****400. Get 5 free credits per month on Saleshandy.Curi Bio and Cook MyoSite Announce Strategic Partnership
SEATTLE & PITTSBURGH--(BUSINESS WIRE)-- #BioTech--Curi Bio and Cook MyoSite Announce Strategic Scientific Collaboration to Advance Translational Human Muscle Disease ModelsCuri Bio Unlocks Advanced Cardiac Insights with Novoheart Integration
SEATTLE & BOSTON--(BUSINESS WIRE)-- #BioTech--Curi Bio Unlocks Advanced Cardiac Insights with Novoheart IntegrationMedera’s Novoheart and Curi Bio Partner to Transform Human-Based Cardiac Drug Screening
BOSTON and SEATTLE, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat or currently incurable diseases with significant unmet needs, today announced that its wholly owned preclinical subsidiary for disease modelling and drug discovery, Novoheart, has entered into a transformative partnership with Curi Bio Inc., a leader in preclinical screening technologies. This strategic collaboration integrates Novoheart
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Curi Bio
Sign Up For FreeTo access detailed company insights
Curi Bio unlocks novel workflows and delivers functional human data to inform biopharmaceutical R&D decision making. Through an integrated platform featuring advanced 3D tissue models of disease, biosystems enabling clinically relevant functional analyses, and advanced automated data analysis, Curi Bio blends functional and analytical assessments f... Read More
